Moleculin Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/13/2024 | 3.21 M | $2.75 M | 100.00% | 10.76% |
| VANGUARD GROUP INC | 03/11/2024 | 1.08 M | $927,177 | 0.00% | 3.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 246,670 | $211,802 | 0.00% | 0.83% |
| BLACKROCK INC. | 02/13/2024 | 188,924 | $162,172 | -3.76% | 0.63% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 129,600 | $111,000 | 7.82% | 0.43% |
| STATE STREET CORP | 02/14/2024 | 71,397 | $61,287 | 0.00% | 0.24% |
| CITADEL ADVISORS LLC | 02/14/2024 | 64,652 | $55,497 | 100.00% | 0.22% |
| NORTHERN TRUST CORP | 02/13/2024 | 53,596 | $46,007 | 0.00% | 0.18% |
| ATTICUS WEALTH MANAGEMENT, LLC | 01/17/2024 | 50,001 | $42,921 | 100.00% | 0.17% |
| SCHMIDT P J INVESTMENT MANAGEMENT INC | 01/29/2024 | 29,000 | $14,094 | 0.00% | 0.10% |
| ROYAL BANK OF CANADA | 02/14/2024 | 20,148 | $17,000 | 100.00% | 0.07% |
| JMAC ENTERPRISES LLC | 01/26/2024 | 13,132 | $11,273 | 0.00% | 0.04% |
| SIGMA PLANNING CORP | 02/01/2024 | 12,000 | $10,301 | -29.41% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 7,201 | $6,178 | -49.66% | 0.02% |
| MORGAN STANLEY | 08/16/2024 | 6,334 | $5,437 | 0.00% | 0.02% |
| SANDY SPRING BANK | 01/26/2024 | 1,333 | $1,145 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/12/2024 | 968 | $831 | 0.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 01/16/2024 | 500 | $429 | 100.00% | 0.00% |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | 01/10/2024 | 250 | $215 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 229 | $197 | -68.06% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2024 | 138 | $118 | 38.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2024 | 52 | $45 | 44.44% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/13/2024 | 2 | $2 | 100.00% | 0.00% |
| FMR LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SIO CAPITAL MANAGEMENT, LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
Moleculin Biotech, Inc.institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Moleculin Biotech, Inc.. The most heavily invested institutionals were:
American Portfolios Advisors: 334
Urban Wealth Management, LLC: 3,019
17.39% of Moleculin Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3,353 shares in the last 24 months. This purchase volume represents approximately $6,102 in transactions.